CN Patent

CN114588124B — 一种延迟释放的药物组合物

Assigned to Jiangsu Hengrui Medicine Co Ltd · Expires 2023-10-20 · 3y expired

What this patent protects

本公开提供一种延迟释放的药物组合物。具体而言，本公开提供的延迟释放的药物组合物包含了含药核心及包覆于含药核心周围的外包层，外包层包含至少一种基质材料，至少一种疏水性的增塑剂和至少一种亲水凝胶骨架材料，所述的延迟释放的药物组合物，提供1‑10h的活性物质的延迟释放。

USPTO Abstract

本公开提供一种延迟释放的药物组合物。具体而言，本公开提供的延迟释放的药物组合物包含了含药核心及包覆于含药核心周围的外包层，外包层包含至少一种基质材料，至少一种疏水性的增塑剂和至少一种亲水凝胶骨架材料，所述的延迟释放的药物组合物，提供1‑10h的活性物质的延迟释放。

Drugs covered by this patent

Patent Metadata

Patent number
CN114588124B
Jurisdiction
CN
Classification
—
Expires
2023-10-20
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Hengrui Medicine Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.